SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-021004
Filing Date
2021-08-23
Accepted
2021-08-23 16:15:36
Documents
12
Period of Report
2021-08-17
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38006
  Complete submission text file 0001493152-21-021004.txt   210535

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pulm-20210817.xsd EX-101.SCH 3027
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pulm-20210817_lab.xml EX-101.LAB 34239
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pulm-20210817_pre.xml EX-101.PRE 22360
5 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3601
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36199 | Film No.: 211197010
SIC: 2834 Pharmaceutical Preparations